Hims & Hers Health, Inc.

NYSE:HIMS

42.35 (USD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 544.833586.01481.139401.556315.648278.171246.619226.699207.912190.77167.203144.836113.563101.31484.69974.17360.69252.31441.46641.32435.90430.06324.76921.68418.05318.053
Cost of Revenue 128.637155.321111.59883.6759.03549.07642.56139.39137.75437.34534.86630.38326.38726.55822.60119.30113.41512.0679.57410.04710.2429.4449.6389.4359.449.44
Gross Profit 416.196430.689369.541317.886256.613229.095204.058187.308170.158153.425132.337114.45387.17674.75662.09854.87247.27740.24731.89231.27725.66220.61915.13112.2498.6138.613
Gross Profit Ratio 0.7640.7350.7680.7920.8130.8240.8270.8260.8180.8040.7910.790.7680.7380.7330.740.7790.7690.7690.7570.7150.6860.6110.5650.4770.477
Reseach & Development Expenses 37.84829.91423.74921.09218.65415.32413.40512.2711.80410.7488.3117.9776.8616.08806.2420000000000
General & Administrative Expenses 67.27348.6148.02844.61740.55434.56832.31935.90731.14430.51350.08926.24622.56721.81140.95637.99836.7461.6985.96619.49614.84114.06415.49217.65711.35711.357
Selling & Marketing Expenses 217.862231.235221.085182.284144.922130.553125.895116.076107.21997.24585.54278.46260.4948.09342.70738.29327.94426.95819.31415.10211.812.77313.17314.11517.93417.934
SG&A 285.135279.845269.113226.901185.476165.121158.214151.983138.363127.758135.631104.70883.05769.90483.66376.29164.68488.65625.2834.59826.64126.83728.66531.77229.29129.291
Other Expenses 66.4963.03358.08347.51941.45338.74732.83931.60929.22726.182021.75117.44815.683000011.2380000000
Operating Expenses 389.473372.792350.945295.512245.583219.192204.458195.862179.394164.688143.942134.436107.36691.67583.66382.53364.68488.65636.51834.59826.64126.83728.66531.77229.29129.291
Operating Income 26.72357.89718.59622.37411.039.903-0.4-8.554-9.236-11.263-11.605-19.983-20.19-16.919-21.565-27.661-17.407-48.409-4.626-3.321-0.979-6.218-13.534-19.523-20.679-20.679
Operating Income Ratio 0.0490.0990.0390.0560.0350.036-0.002-0.038-0.044-0.059-0.069-0.138-0.178-0.167-0.255-0.373-0.287-0.925-0.112-0.08-0.027-0.207-0.546-0.9-1.145-1.145
Total Other Income Expenses Net 6.132.5983.6951.2192.3942.52.5961.6382.0661.5820.5771.1270.5230.761-9.6838.5478.288-2.905-0.579-2.5190.0350.221.2010.880.180.18
Income Before Tax 32.85360.49522.29123.59313.42412.4032.196-6.916-7.17-9.681-11.028-18.856-19.667-16.158-31.248-19.114-9.119-51.314-5.205-5.84-0.944-5.998-12.333-18.643-20.499-20.499
Income Before Tax Ratio 0.060.1030.0460.0590.0430.0450.009-0.031-0.034-0.051-0.066-0.13-0.173-0.159-0.369-0.258-0.15-0.981-0.126-0.141-0.026-0.2-0.498-0.86-1.136-1.136
Income Tax Expense -9.65211.01-3.734-51.9950.1271.2750.9510.651-0.0130.386-0.121-0.0160.0120.094-0.087-3.1730.0340.090.0240.0310.0370.0350.0230.0220.0230.023
Net Income 42.50549.48526.02575.58813.29711.1281.245-7.567-7.157-10.067-10.907-18.84-19.679-16.252-31.161-15.941-9.153-51.404-5.229-5.871-0.981-6.033-12.356-18.665-20.522-20.522
Net Income Ratio 0.0780.0840.0540.1880.0420.040.005-0.033-0.034-0.053-0.065-0.13-0.173-0.16-0.368-0.215-0.151-0.983-0.126-0.142-0.027-0.201-0.499-0.861-1.137-1.137
EPS 0.190.220.120.350.0620.050.006-0.036-0.034-0.049-0.053-0.092-0.097-0.08-0.15-0.08-0.048-0.34-0.07-0.16-0.03-0.17-0.32-0.48-0.54-0.54
EPS Diluted 0.170.20.110.320.0570.050.006-0.036-0.034-0.049-0.053-0.092-0.097-0.08-0.15-0.08-0.048-0.34-0.07-0.16-0.03-0.17-0.32-0.48-0.54-0.54
EBITDA 37.18866.17324.65726.75714.67312.9042.258-6.191-6.859-9.146-9.595-18.081-18.369-15.178-29.618-26.115-16.902-48.015-2.007-5.54-0.732-5.808-12.15-19.428-20.671-20.671
EBITDA Ratio 0.0680.1130.0510.0670.0460.0460.009-0.027-0.033-0.048-0.057-0.125-0.162-0.15-0.35-0.352-0.278-0.918-0.048-0.134-0.02-0.193-0.491-0.896-1.145-1.145